Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modulation of c-FOS and BDNF protein expression in pentylenetetrazole-kindled mice following the treatment with novel anti-epileptic compound HHL-6

Modulation of c-FOS and BDNF protein expression in pentylenetetrazole-kindled mice following the treatment with novel anti-epileptic compound HHL-6

US Patent 9272998 · Granted Mar 1, 2016

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Nasally administered pharmaceutical composition for the treatment of epilepsy an2022
Isoxylitones mediated neurogenesis2021
Anticancer peptides2020
Antitubercular alkaloid2013
Steroidal antitubercular compounds2013
Steroidal antitubercular compounds2013
Anticonvulsant compounds2008